Dendreon files Provenge BLA

Earlier this week, Dendreon completed its revised BLA for Provenge, taking another big step along the road to marketing a new prostate cancer therapy. Dendreon beat its own timetable and hopes to launch the therapeutic cancer vaccine in 2010. Dendreon release | Story

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.